Market cap
₹0 Cr
Revenue (TTM)
₹1,606 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
-- %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 24.10 | 20.50 | 21.83 |
| EBIT | -- | -- | 627.46 | 206.96 | 86.29 |
| Net Profit | -- | -- | 175.60 | 44.61 | 30.11 |
| EPS | -- | -- | 173.07 | 40.03 | 26.45 |
| Book Value | -- | -- | 35.97 | 112.10 | 26.66 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 8.77 | 3.87 | 10.74 | 1.83 | 3.61 |
| Net Margin
| 4.45 | -1.90 | 2.69 | -4.41 | -1.32 |
| Return on equity
| 12.39 | -23.07 | 12.99 | -18.73 | -8.32 |
| Return on Capital
| 15.44 | 10.60 | 17.30 | 4.63 | 11.61 |
| Return on Assets
| 3.44 | -1.57 | 2.26 | -3.53 | -1.11 |
| Debt to Equity (x)
| -- | -- | 2.16 | 2.60 | 1.62 |
Profitability
ROCE
17.30
Higher than Peers by 1.13
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
17.30
|
4.63
|
11.61
|
6.77
|
12.69
|
|
Peer Median
|
16.17
|
19.08
|
17.78
|
15.96
|
--
|
ROE
12.99
Lower than Peers by 0.97
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
12.99
|
-18.73
|
-8.32
|
-82.92
|
-18.37
|
|
Peer Median
|
13.96
|
14.26
|
17.43
|
16.41
|
--
|
ROA
2.26
Lower than Peers by 6.73
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
2.26
|
-3.53
|
-1.11
|
-3.79
|
-1.67
|
|
Peer Median
|
8.99
|
9.57
|
8.31
|
7.08
|
--
|
EBIT Margin
10.74
Lower than Peers by 5.17
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
10.74
|
1.83
|
3.61
|
0.65
|
2.53
|
|
Peer Median
|
15.91
|
17.87
|
18.12
|
12.75
|
--
|
Net Margin
2.69
Lower than Peers by 9.18
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
2.69
|
-4.41
|
-1.32
|
-4.57
|
-1.87
|
|
Peer Median
|
11.87
|
9.83
|
9.95
|
9.16
|
--
|
Cash Profit Margin
11.67
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
11.67
|
4.45
|
5.79
|
2.47
|
4.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
24.10
Higher than Peers by 6.32
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
24.10
|
14.62
|
23.00
|
17.69
|
30.33
|
|
Peer Median
|
17.79
|
16.25
|
16.01
|
16.23
|
--
|
EBIT Growth
627.46
Higher than Peers by 604.25
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
627.46
|
-41.80
|
583.11
|
-69.79
|
333.86
|
|
Peer Median
|
23.21
|
19.31
|
20.43
|
18.62
|
--
|
Net Profit Growth
175.60
Higher than Peers by 150.76
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
175.60
|
-278.21
|
64.17
|
-188.98
|
41.59
|
|
Peer Median
|
24.84
|
17.42
|
25.57
|
23.10
|
--
|
EPS Growth
173.07
Higher than Peers by 151.03
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
173.07
|
-278.22
|
73.02
|
-188.99
|
42.79
|
|
Peer Median
|
22.04
|
16.25
|
--
|
50.00
|
--
|
Book Value Growth
40.68
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
40.68
|
-17.14
|
1,024.39
|
-58.82
|
-17.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
2.16
Higher than Peers by 1.90
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
2.16
|
2.60
|
1.62
|
13.11
|
2.93
|
|
Peer Median
|
0.27
|
0.31
|
0.39
|
0.37
|
--
|
Short term debt to equity ratio
0.82
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
0.82
|
0.81
|
0.44
|
3.55
|
0.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.08
Lower than Peers by 0.44
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
1.08
|
0.84
|
0.89
|
0.55
|
1.46
|
|
Peer Median
|
1.51
|
1.37
|
1.58
|
1.32
|
--
|
Quick Ratio
1.03
Lower than Peers by 0.71
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
1.03
|
0.79
|
0.82
|
0.52
|
1.41
|
|
Peer Median
|
1.74
|
2.06
|
1.03
|
1.32
|
--
|
Interest Coverage
1.64
Lower than Peers by 5.23
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
1.64
|
0.47
|
1.10
|
0.47
|
1.09
|
|
Peer Median
|
6.87
|
7.55
|
5.83
|
5.17
|
--
|
Operating Efficiency
Debtors to sales
21.77
Higher than Peers by 12.72
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
21.77
|
18.13
|
13.84
|
14.24
|
10.82
|
|
Peer Median
|
9.05
|
9.95
|
8.40
|
10.55
|
--
|
Asset Turnover
0.83
Higher than Peers by 0.10
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
0.83
|
0.79
|
0.82
|
0.81
|
0.88
|
|
Peer Median
|
0.72
|
0.72
|
0.80
|
0.85
|
--
|
Receivable days
66.38
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
66.38
|
55.13
|
46.39
|
42.76
|
29.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
6.61
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
6.61
|
7.63
|
7.36
|
5.97
|
5.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
169.10
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
169.10
|
177.72
|
160.66
|
187.55
|
195.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-96.11
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Paras Healthcare
|
-96.11
|
-114.96
|
-106.92
|
-138.82
|
-160.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|